These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29357957)

  • 1. Double sequential cardioversion for refractory ventricular tachycardia: A case report.
    Sheikh H; Xie E; Austin E
    CJEM; 2018 Oct; 20(S2):S56-S60. PubMed ID: 29357957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of defibrillation shocks for resuscitation of rapid ventricular tachycardia: does it make a difference?
    Turner I; Turner S; Grace AA
    Resuscitation; 2009 Feb; 80(2):183-8. PubMed ID: 19091453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of shock timing on efficacy and safety of internal cardioversion for ventricular tachycardia.
    Li HG; Yee R; Mehra R; DeGroot P; Klein GJ; Zardini M; Thakur RK; Morillo CA
    J Am Coll Cardiol; 1994 Sep; 24(3):703-8. PubMed ID: 8077542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
    Long B; Koyfman A
    J Emerg Med; 2017 Apr; 52(4):484-492. PubMed ID: 27751700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion.
    Bardy GH; Poole JE; Kudenchuk PJ; Dolack GL; Kelso D; Mitchell R
    Circulation; 1993 Jun; 87(6):1889-96. PubMed ID: 8504501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External Defibrillator Damage Associated With Attempted Synchronized Dual-Dose Cardioversion.
    Gerstein NS; McLean AR; Stecker EC; Schulman PM
    Ann Emerg Med; 2018 Jan; 71(1):109-112. PubMed ID: 28559035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inconsistent shock advisories for monomorphic VT and Torsade de Pointes--A prospective experimental study on AEDs and defibrillators.
    Fitzgerald A; Johnson M; Hirsch J; Rich MA; Fidler R
    Resuscitation; 2015 Jul; 92():137-40. PubMed ID: 25724355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of monophasic and biphasic defibrillating pulse waveforms for transthoracic cardioversion. Biphasic Waveform Defibrillation Investigators.
    Greene HL; DiMarco JP; Kudenchuk PJ; Scheinman MM; Tang AS; Reiter MJ; Echt DS; Chapman PD; Jazayeri MR; Chapman FW
    Am J Cardiol; 1995 Jun; 75(16):1135-9. PubMed ID: 7762500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitachycardia pacing and low-energy cardioversion for ventricular tachycardia termination: a clinical perspective.
    Estes NA; Haugh CJ; Wang PJ; Manolis AS
    Am Heart J; 1994 Apr; 127(4 Pt 2):1038-46. PubMed ID: 8160578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular fibrillation induced by low-energy shocks from programmable implantable cardioverter-defibrillators in patients with coronary artery disease.
    Lauer MR; Young C; Liem LB; Ottoboni L; Peterson J; Goold P; Sung RJ
    Am J Cardiol; 1994 Mar; 73(8):559-63. PubMed ID: 8147300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular tachycardia converts to sinus rhythm after administration of propofol.
    Shannon K; Saltzman D; Li I; Mokszycki R; Galletta G
    Am J Emerg Med; 2021 Oct; 48():377.e1-377.e3. PubMed ID: 33875319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular tachycardia initiated by high energy cardioversion in a patient with an implantable cardioverter defibrillator.
    Chinushi M; Aizawa Y; Higuchi K
    Heart; 1997 Apr; 77(4):373-4. PubMed ID: 9155621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher energy synchronized external direct current cardioversion for refractory atrial fibrillation.
    Saliba W; Juratli N; Chung MK; Niebauer MJ; Erdogan O; Trohman R; Wilkoff BL; Augostini R; Mowrey KA; Nadzam GR; Tchou PJ
    J Am Coll Cardiol; 1999 Dec; 34(7):2031-4. PubMed ID: 10588220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Termination and acceleration of ventricular tachycardia with autodecremental pacing, burst pacing, and cardioversion in patients with an implantable cardioverter defibrillator. Multicenter PCD Investigator Group.
    Hammill SC; Packer DL; Stanton MS; Fetter J
    Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 1):3-10. PubMed ID: 7700828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular tachycardia with hemodynamic instability refractory to cardioversion: a case report.
    Chou CJ; Lee CS; Lai WT
    Kaohsiung J Med Sci; 2009 Dec; 25(12):675-9. PubMed ID: 19951854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
    Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
    Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of transvenous low energy cardioversion of atrial fibrillation in patients with a history of ventricular tachycardia: effects of rate and repolarization time on proarrhythmic risk.
    Simons GR; Newby KH; Kearney MM; Brandon MJ; Natale A
    Pacing Clin Electrophysiol; 1998 Feb; 21(2):430-7. PubMed ID: 9507545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of approximate entropy measurements to classify ventricular tachycardia and fibrillation.
    Schuckers SA
    J Electrocardiol; 1998; 31 Suppl():101-5. PubMed ID: 9988012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute management of ventricular arrhythmias: role of antiarrhythmic agents.
    Singh BN
    Pharmacotherapy; 1997; 17(2 Pt 2):56S-64S; discussion 89S-91S. PubMed ID: 9085341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.